REICIN ALISE — SEC Form 4 filings
SEC reporting owner CIK 1757533. 17 Form 4 filings on record with FilingPulse; latest filed 2026-09-08.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2024-06-07 to 2026-09-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 5,000 shares, $105,500 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 24.
- Largest priced transaction: purchase of 2,500 shares @ $21.10 ($52,750) in Tectonic Therapeutic, Inc., filed 2026-03-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Tectonic Therapeutic, Inc. (TECX) | Chief Executive Officer, Director | 12 | 2 legs · 5,000 sh · $105,500 | — | 19 |
| Sana Biotechnology, Inc. (SANA) | Director | 4 | — | — | 4 |
| Immatics N.V. (IMTX) | Director | 1 | — | — | 1 |
Form 4 filings — REICIN ALISE
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-08 | 4 | Tectonic Therapeutic, Inc. (TECX) | Grant/award (A): 69,250 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | Tectonic Therapeutic, Inc. (TECX) | Tax withholding (F): 924 @ $30.34 | EDGAR |
| 2026-06-18 | 4 | Immatics N.V. (IMTX) | Grant/award (A): 48,000 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4/A | Tectonic Therapeutic, Inc. (TECX) | Purchase (P): 2,500 @ $21.10 | EDGAR |
| 2026-03-05 | 4 | Tectonic Therapeutic, Inc. (TECX) | Grant/award (A): 76,500 @ $0 · Grant/award (A): 69,250 (derivative) @ $0 | EDGAR |
| 2026-02-12 | 4 | Tectonic Therapeutic, Inc. (TECX) | Purchase (P): 2,500 @ $21.10 | EDGAR |
| 2026-02-10 | 4 | Tectonic Therapeutic, Inc. (TECX) | Tax withholding (F): 4,104 @ $23.22 | EDGAR |
| 2026-01-05 | 4 | Tectonic Therapeutic, Inc. (TECX) | Option exercise (M): 10,966 @ $2.38 · Option exercise (M): 10,966 (derivative) | EDGAR |
| 2025-09-29 | 4 | Tectonic Therapeutic, Inc. (TECX) | Grant/award (A): 14,700 @ $0 · Grant/award (A): 26,710 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | Tectonic Therapeutic, Inc. (TECX) | Tax withholding (F): 859 @ $19.81 | EDGAR |
| 2025-06-09 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2025-02-06 | 4 | Tectonic Therapeutic, Inc. (TECX) | Grant/award (A): 36,047 @ $0 · Grant/award (A): 101,953 (derivative) @ $0 | EDGAR |
| 2024-12-06 | 4 | Tectonic Therapeutic, Inc. (TECX) | Grant/award (A): 11,717 @ $0 · Grant/award (A): 6,000 (derivative) @ $0 | EDGAR |
| 2024-07-15 | 4/A | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Tectonic Therapeutic, Inc. (TECX) | Grant/award (A): 166,580 · Grant/award (A): 124,530 · Grant/award (A): 33,923 (derivative) · Grant/award (A): 23,380 (derivative) · Grant/award (A): 289,600 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Sana Biotechnology, Inc. (SANA) | Grant/award (A): 54,278 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1757533 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →